• Englishen
  • Françaisfr
  • Claude Meunier

    événements, séminaires

    7 Octobre 2022 – Fekrije Selimi  (Collège de France, Paris)- The developmental history of the molecular synaptic code controlling excitatory connectivity

    The mature brain results from the formation of precise networks between functionally and morphologically distinct types of neurons. A given neuron forms synapses with a limited number of partners and on precise subcellular localizations. Understanding what controls this specificity is…  Continue reading

    événements, séminaires

    23 Septembre 2022 – Sébastian Bouret (ICM, Paris) – Neural basis of decision-making in primates. In the lab and beyond

    The presentation will cover the cognitive and neurobiological functions underlying cost-benefits decision making in primates. After covering data from laboratory experiments, I will present recent studies aimed at understanding how these data can help understand how specific neuro-cognitive operations allow…  Continue reading

    événements, séminaires

    24 Juin 2022 – Pierre Paoletti (Institut de Biologie de l’ENS, Paris) – New lights on neurotransmission: from molecular optogenetics to excitatory glycine receptors

    The function of the human brain and its remarkable capacity for information storage and experience-dependent change hinge on the dynamics of chemical synapses – main ‘contact points’ between neurons. My team has a long-standing interest in studying the molecular principles…  Continue reading

    événements, rencontres INC

    21 Juin 2022 – Sixième rencontre du Club Autisme, autres troubles du neurodéveloppement et Vision (CAV)

    Le thème de cette sixième rencontre du CAV est Variabilités sensorielles dans l’autisme et les TND.  Elle  se tiendra le mardi 21 juin 2022 de 14h30 à 16h00 en visioconférence . Le lien zoom pour participer est  https://u-paris.zoom.us/j/83362729793?pwd=R2FBWnRyNHB4L0grYWRMbC9YUGpqdz09 Comité d’organisation…  Continue reading

    événements, séminaires

    Jeudi, 12 Mai 2022 – Melissa Bowerman (Keele University, UK) – Combining bioinformatic and drug repurposing approaches to develop second-generation therapies for spinal muscular atrophy

    Spinal muscular atrophy (SMA) is a devastating childhood disease caused by loss of function of the survival motor neuron (SMN) gene, leading to the death of nerve and muscle cells. The first SMN gene replacement therapies have recently been approved…  Continue reading